Director of Orthopaedic Research at Jersey City Medical Center, Barnabas Health
Use of ViviGen® Cellular Bone Allograft in Orthopaedic Trauma.
Do We Even Need Iliac Crest Anymore?
Orthopaedic Center
Podiatric Medicine & Surgery Section
Gundersen Healthcare System
Dr. Roukis discusses his findings in a retrospective study of these two cellular bone allografts. He shares his thoughts and experience with both the lineage-committed bone cell product, ViviGen and the MSC-based cellular allograft Trinity.
MD, Foot & Ankle Trauma Surgeon, University of Virginia Medical Center
Dr. Park published the largest study to date examining the use of ViviGen for augmentation for fusion or ORIF in foot and ankle surgeries. Findings in this review suggest that ViviGen is capable of achieving high fusion rates, even in patients with comorbitities.
Cellular Bone Matrix and Fusion Outcomes in Challenging Patient Population.
Dr. Jeffrey Marschall on his use of ViviGen in complex CMF procedures
Dr. Hall discusses his use of ViviGen to achieve fusion in patients in even his most challenging situations.
Dr. Alan Ng, a podiatric foot and ankle surgeon in Denver shares his experience with ViviGen
Dr. Yoon discusses his use of ViviGen in challenging trauma cases and the multi-center clinical study underway to evaluate the safety and efficacy of ViviGen in fracture and fusion settings.
Dr. Park shares his experience using ViviGen Cellular Bone Matrix.